Presentation is loading. Please wait.

Presentation is loading. Please wait.

This presentation may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number.

Similar presentations


Presentation on theme: "This presentation may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number."— Presentation transcript:

1

2 This presentation may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.

3 BOVIE = ELECTROSURGERY
Surgical instruments in the OR that are related to electrosurgery are called by the name “BOVIE.” Branding the “Bovie” name within the medical community Over 32 million surgical procedures in U.S.

4 High & Low Temperature Cauteries

5

6 Targeted towards the Gastroenterology market.
Over $150 million market including accessories growing 7-9% per year 13,000 operating centers Icon platform provides the basis to develop customized generators for other specialties (ex. Oncology $200 million).

7

8 SEER Tissue Resection Device
Saline Enhanced Electrosurgical Resection Delivers RF current & sterile saline for resection and coagulation Lowers blood loss, procedure times and cost savings for hospitals Liver, pancreatic, kidney tumor removal Received FDA 510(k) clearance Feb. 2009

9

10 BOSS Tissue Resection Device
Bipolar Orthopedic Surgical Sealer Orthopedic and laparoscopic surgeries Hip, knee and spinal fusion surgeries Estimated over 1 million procedures performed annually Projected to grow 5% per year Subject to 510(k) application Estimated $500 million worldwide market for tissue coagulation

11 MEG/Polarian™ Instrument Lines
The only product that may compete in three markets and address all areas of minimally invasive surgeries: Arthroscopy Instrument Market $200 million Laparoscopy Instrument Market $300 million Vessel Sealing Market $500 million MEG line received 510(k) clearance 2008. Polarian Vessel subject to FDA 510(k) clearance.

12 MEG Line of Instruments

13 Arthroscopy Instrument
Market research indicates little to no innovation from top five companies in this space over the past 15 years. Can dramatically reduce cost to the end user. The only arthroscopy instrument with a flushing port for cleaning. One tip design can replace multiple instruments.

14 Laparoscopy Instrument
Handle accepts inserts from 2mm to 12mm Cancelable ratchet feature can be activated either left or right handed. Ergonomic handle reduces fatigue and creates more leverage. Modular design can significantly reduce cost Metallic handle is electrically isolated to increase instrument life.

15 Vessel Sealing Instrument
Only modular designed laparoscopic VS instrument Handle can accommodate both “open” and laparoscopic instrument tips. “Seal and Cut” design. Can be used with existing vessel sealing generators or user can gain enhanced benefits with Bovie generator. Significantly reduces costs. Largest (total market size $500 million) and fastest growing (10-15%) segment with highest margins. Subject to FDA 510(k) application

16 Ergonomic 360 Rotation of cartridge Electrode quick attachment detachment Can be controlled by three triggers: Jaw trigger Coagulation + sealing trigger Powered blade trigger

17 and many other open surgery adaptations
Suitable for a variety of endoscopic Bipolar AND Monopolar or Inert applications like Vessel Sealing Laparoscopy Endo GYN Arthroscopy Urology Thoracic Endoscopy Sinoscopy and many other open surgery adaptations

18 ICON GS Plasma System J-Plasma is formed by holding a sharp conductive point at High Voltage and High Frequency, over which an Inert Gas, such as Helium, flows.

19

20 ICON GS Plasma System Produces a stable thin focused beam of ionized helium gas Provides minimal invasiveness and precision No conductive currents during surgery Highly localized effect Minimal collateral damage of healthy tissue Absence of return electrode and grounding issues Wide range of power control Independent control of beam power (Heating) and helium flow rate (Cooling) Subject to FDA 510(k) clearance (application filed March 2009)

21

22 Contact Information Bovie Medical, Inc. Suite 207, 734 Walt Whitman Road Melville, NY 11747 Buttonwood Advisory Group, Inc. 15705 Framingham Lane Huntersville, NC 28078


Download ppt "This presentation may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number."

Similar presentations


Ads by Google